Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats.

Source:http://linkedlifedata.com/resource/pubmed/id/9840211

Download in:

View as

General Info

PMID
9840211